All Stories

  1. Randomized Trial of Very Early Medication Abortion
  2. A post-abortion contraception text-and-call service to support patients to access effective contraception after telemedicine abortion
  3. Abortion patients’ perspectives on enhancing a telemedicine model of post-abortion contraception: a qualitative study
  4. Using telemedicine to improve early medical abortion at home (UTAH): a randomised controlled trial to compare telemedicine with in-person consultation for early medical abortion
  5. Feasibility of methadone for pain relief in first trimester abortion
  6. Very early medical abortion: treatment with mifepristone and misoprostol before ultrasonographic visualisation of an intrauterine pregnancy
  7. Medical Abortion before Confirmed Intrauterine Pregnancy: A Systematic Review
  8. PAIN management for medical abortion before 14 weeks’ gestation: A systematic review
  9. Self-reported contraceptive use and satisfaction among women accessing telemedicine medical abortion at the onset of the COVID-19 pandemic at 3–6-month follow-up
  10. Uptake of long-acting reversible contraception after telemedicine delivered abortion during Covid-19
  11. Pain management for medical abortion before 14 weeks’ gestation
  12. Views of clinicians towards providing contraceptive advice and contraception to women following early pregnancy loss: a qualitative study
  13. Mifepristone at home
  14. A qualitative study of abortion care providers’ perspectives on telemedicine medical abortion provision in the context of COVID-19
  15. How people use tablets when having a medical abortion, and what side effects they experience.
  16. Women’s experiences of a telemedicine abortion service (up to 12 weeks) implemented during the coronavirus (COVID‐19) pandemic: a qualitative evaluation
  17. UTAH: Using Telemedicine to improve early medical Abortion at Home: a protocol for a randomised controlled trial comparing face-to-face with telephone consultations for women seeking early medical abortion
  18. Will Men Use Novel Male Contraceptive Methods and Will Women Trust Them? A Systematic Review
  19. Venus
  20. Telemedicine medical abortion at home under 12 weeks’ gestation: a prospective observational cohort study during the COVID-19 pandemic
  21. Venus
  22. Utility of a routine ultrasound for detection of ectopic pregnancies among women requesting abortion: a retrospective review
  23. Troublesome bleeding following early medical abortion
  24. Predicting human conception: the elusive ‘fertility test’
  25. Venus
  26. Venus
  27. Sexual behaviour, pregnancy intention and sexually transmitted infection risk varies extensively among transgender and non-binary patients in the UK
  28. Animations can provide information on early medical abortion
  29. Correction: Male contraception: where are we going and where have we been?
  30. High rates of treatment failure for Mycoplasma genitalium among men and women attending a sexual health clinic
  31. Male Contraception: Review of literature and future developments.
  32. Delayed presentation of uterine and bowel perforation following insertion of an intrauterine device
  33. Accuracy of a point-of-care test for quantifying human chorionic gonadotrophin (hCG) in the management of pregnancy of unknown location in an abortion service
  34. Venus
  35. Better political and legal protection to improve sex workers’ health
  36. Venus
  37. Book of Abstracts: The 15th Congress of the European Society of Contraception and Reproductive Health
  38. O30 Treatment failure in mycoplasma genitalium among gum clinic attendees
  39. P017 Managing mycoplasma genitalium in clinic: don’t forget the partners
  40. Mycoplasma genitalium: a new kid on the block
  41. O032 Implementing a test and treat pathway forMycoplasma genitaliumin men with urethritis attending a GUM clinic
  42. The moral and philosophical importance of abortion